Dow Jones

39 121,38

0,02%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Generex Biotechnology Corporation (CE) (GNBT)
Generex Biotechnology Corporation (CE) (GNBT) Actualités

GNBT

Generex Biotechnology (CE) (GNBT)

Generex Biotechnology Corporation (CE)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:GNBT

1 2 3 4 5 6 7 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
23/07/2021	13h10	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:GNBT	Generex Biotechnology Corporation (CE)
21/06/2021	21h09	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:GNBT	Generex Biotechnology Corporation (CE)
14/06/2021	23h01	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:GNBT	Generex Biotechnology Corporation (CE)
29/10/2020	22h01	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:GNBT	Generex Biotechnology Corporation (CE)
06/10/2020	19h29	InvestorsHub NewsWire	(GNBT,PAOG) SPAC Trend Comes To Biotech Market	USOTC:GNBT	Generex Biotechnology Corporation (CE)
21/09/2020	15h33	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:GNBT	Generex Biotechnology Corporation (CE)
11/09/2020	22h00	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:GNBT	Generex Biotechnology Corporation (CE)
09/09/2020	18h54	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:GNBT	Generex Biotechnology Corporation (CE)
31/08/2020	16h03	InvestorsHub NewsWire	GNBT - Vying for vaccines	USOTC:GNBT	Generex Biotechnology Corporation (CE)
20/08/2020	23h17	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:GNBT	Generex Biotechnology Corporation (CE)
29/06/2020	20h29	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	USOTC:GNBT	Generex Biotechnology Corporation (CE)
19/06/2020	19h10	Edgar (US Regulatory)	Withdrawal of Registration Statement (ammendment) (aw)	USOTC:GNBT	Generex Biotechnology Corporation (CE)
04/05/2020	16h02	InvestorsHub NewsWire	Generex Biotechnology Initiates Peptide Manufacturing for Ii-Key- SARS-CoV-2 Peptide Vaccine Against the COVID-19 Pandemic	USOTC:GNBT	Generex Biotechnology Corporation (CE)
28/04/2020	20h05	InvestorsHub NewsWire	Generex Subsidiary NuGenerex Immuno-Oncology Announces Publication of Positive Results of the AE37 Phase IIb Breast Cancer Tr...	USOTC:GNBT	Generex Biotechnology Corporation (CE)
27/04/2020	18h07	InvestorsHub NewsWire	GNBT Publishes Response to Congressional Letter Calling for COVID-19 Challenge Studies and Alternative Solutions	USOTC:GNBT	Generex Biotechnology Corporation (CE)
13/02/2020	20h05	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:GNBT	Generex Biotechnology Corporation (CE)
29/11/2019	19h34	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:GNBT	Generex Biotechnology Corporation (CE)
25/11/2019	17h45	InvestorsHub NewsWire	GNBT - Generex Biotechnology Signs Stock Purchase Agreement to Acquire 51% of ALTuCELL, Inc.	USOTC:GNBT	Generex Biotechnology Corporation (CE)
12/11/2019	15h31	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:GNBT	Generex Biotechnology Corporation (CE)
05/11/2019	16h38	InvestorsHub NewsWire	GNBT Announces First-in-Human Clinical Trial of ALTuCELL Cellular Therapy Product Altsulin® (Microencapsulated Sertoli C...	USOTC:GNBT	Generex Biotechnology Corporation (CE)
31/10/2019	15h51	InvestorsHub NewsWire	GNBT - BioPharma w/10x Potential - Cancer and Diabetes Treatments - Nasdaq Up List	USOTC:GNBT	Generex Biotechnology Corporation (CE)
29/10/2019	20h11	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:GNBT	Generex Biotechnology Corporation (CE)
23/10/2019	20h32	InvestorsHub NewsWire	WHY GNBT COULD MOVE BIG SOON	USOTC:GNBT	Generex Biotechnology Corporation (CE)
01/10/2019	18h37	InvestorsHub NewsWire	Generex Biotechnology Subsidiary Olaregen Therapeutix Launches Excellagen Wound Conforming Matrix 3.0 cc Pre-Filled Syringe	USOTC:GNBT	Generex Biotechnology Corporation (CE)
24/09/2019	22h34	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:GNBT	Generex Biotechnology Corporation (CE)
18/09/2019	15h26	InvestorsHub NewsWire	GNBT - GENEREX BIOTECHNOLOGY ASSEMBLING MASSIVE GROWTH MACHINE	USOTC:GNBT	Generex Biotechnology Corporation (CE)
17/09/2019	15h29	InvestorsHub NewsWire	GNBT Announces 1st Phase II Clinical Trial Patient for Treatment of Triple Negative Breast Cancer	USOTC:GNBT	Generex Biotechnology Corporation (CE)
12/09/2019	19h29	InvestorsHub NewsWire	GNBT Announces On-Demand Corprate Webcast From 21st Annual H.C. Wainwright Global Healthcare Investment Conference	USOTC:GNBT	Generex Biotechnology Corporation (CE)
11/09/2019	21h46	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:GNBT	Generex Biotechnology Corporation (CE)
10/09/2019	17h34	InvestorsHub NewsWire	GNBT - Generex Signs LOI to Establish NuGenerex Health MSO with Arizona Endocrinology Center & Paradise Valley Family Medicine	USOTC:GNBT	Generex Biotechnology Corporation (CE)